Uromodulin and its association with urinary metabolites: the German Chronic Kidney Disease Study
Nephrology Dialysis Transplantation · 2023
DOI: 10.1093/ndt/gfac187 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Helena Bächle und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center-University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Else Kroener Fresenius Foundation, BMBF, EQUIP Program for Medical Scientists.
Abstract (Originalsprache)
Background
The progression of chronic kidney disease (CKD), a global public health burden, is accompanied by a declining number of functional nephrons. Estimation of remaining nephron mass may improve assessment of CKD progression. Uromodulin has been suggested as a marker of tubular mass. We aimed to identify metabolites associated with uromodulin concentrations in urine and serum to characterize pathophysiologic alterations of metabolic pathways to generate new hypotheses regarding CKD pathophysiology.
Methods
We measured urinary and serum uromodulin levels (uUMOD, sUMOD) and 607 urinary metabolites and performed cross-sectional analyses within the German Chronic Kidney Disease study (N = 4628), a prospective observational study. Urinary metabolites significantly associated with uUMOD and sUMOD were used to build weighted metabolite scores for urine (uMS) and serum uromodulin (sMS) and evaluated for time to adverse kidney events over 6.5 years.
Results
Metabolites cross-sectionally associated with uromodulin included amino acids of the tryptophan metabolism, lipids and nucleotides. Higher levels of the sMS [hazard ratio (HR) = 0.73 (95% confidence interval 0.64; 0.82), P = 7.45e-07] and sUMOD [HR = 0.74 (95% confidence interval 0.63; 0.87), P = 2.32e-04] were associated with a lower risk of adverse kidney events over time, whereas uUMOD and uMS showed the same direction of association but were not significant.
Conclusions
We identified urinary metabolites associated with urinary and serum uromodulin. The sUMOD and the sMS were associated with lower risk of adverse kidney events among CKD patients. Higher levels of sUMOD and sMS may reflect a higher number of functional nephrons and therefore a reduced risk of adverse kidney outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Genetic Epidemiology, Faculty of Medicine and Medical Center-University of Freiburg, Freiburg, Germany.
- Department of Medicine IV-Nephrology and Primary Care, Faculty of Medicine and Medical Center-University of Freiburg, Freiburg, Germany.
- Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
- Department of Nephrology and Medical Intensive Care, Charité, University-Medicine, Berlin, Germany.
- Institute of Genetic Epidemiology, Department of Genetics and Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.
- Institute of Physiology, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Helena Bächle, Peggy Sekula, Pascal Schlosser, Inga Steinbrenner, Helena Stockmann, Kai-Uwe Eckardt, Olivier Devuyst
Förderung
- Else Kroener Fresenius Foundation
- BMBF
- EQUIP Program for Medical Scientists
- Faculty of Medicine, University of Freiburg
- KfH Foundation for Preventive Medicine
- NCCR Kidney
- Swiss National Science Foundation
Zitieren
APA
Bächle, H., Sekula, P., Schlosser, P., Steinbrenner, I., Cheng, Y., Kotsis, F., Meiselbach, H., Stockmann, H., Schönherr, S., Eckardt, K. U., Devuyst, O., Scherberich, J., Köttgen, A., Schultheiss, U. T., & GCKD investigators (2023). Uromodulin and its association with urinary metabolites: the German Chronic Kidney Disease Study. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfac187
Vancouver
Bächle H, Sekula P, Schlosser P, Steinbrenner I, Cheng Y, Kotsis F, et al. Uromodulin and its association with urinary metabolites: the German Chronic Kidney Disease Study. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfac187
BibTeX
@article{Bchle2023,
author = {Bächle, Helena and Sekula, Peggy and Schlosser, Pascal and Steinbrenner, Inga and Cheng, Yurong and Kotsis, Fruzsina and Meiselbach, Heike and Stockmann, Helena and Schönherr, Sebastian and Eckardt, Kai-Uwe and Devuyst, Olivier and Scherberich, Jürgen and Köttgen, Anna and Schultheiss, Ulla T and GCKD investigators, GCKD investigators},
title = {Uromodulin and its association with urinary metabolites: the German Chronic Kidney Disease Study},
journal = {Nephrology Dialysis Transplantation},
year = {2023},
doi = {10.1093/ndt/gfac187}
}
EUVIMED